Ubs Asset Management Americas Inc Singular Genomics Systems, Inc. Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.86 - $6.44 $286,065 - $644,148	-100,023 Reduced 25.52%	291,981 $1.12 Million
Q1 2022 May 16, 2022	SELL	$5.94 - $12.09 $1.13 Million - $2.3 Million	-190,551 Reduced 32.71%	392,004 $2.47 Million
Q4 2021 Feb 14, 2022	SELL	$10.45 - $16.9 $285,201 - $461,234	-27,292 Reduced 4.48%	582,555 $6.73 Million
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $1.02 Million - $2.59 Million	93,589 Added 18.13%	609,847 $6.82 Million
Q2 2021 Aug 16, 2021	BUY	$23.16 - $31.17 $12 Million - $16.1 Million	516,258 New	516,258 $14.2 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.41B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.